1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Morphochem AG Acquires Small Molecule Therapeutics

M&A Deal Summary

Morphochem AG Acquires Small Molecule Therapeutics

On March 20, 2000, Morphochem AG acquired life science company Small Molecule Therapeutics

Acquisition Highlights
  • This is Morphochem AG’s 1st transaction in the Life Science sector.
  • This is Morphochem AG’s 1st transaction in the United States.
  • This is Morphochem AG’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2000-03-20
Target Small Molecule Therapeutics
Sector Life Science
Buyer(s) Morphochem AG
Deal Type Add-on Acquisition

Target

Small Molecule Therapeutics

Monmouth Junction, New Jersey, United States
Small Molecule Therapeutics, Inc. operates as a drug discovery company in the United States

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Morphochem AG

Munich, Germany
Category Company
Founded 1996
Sector Life Science
DESCRIPTION

Morphochem AG is a rapidly growing biopharmaceutical company with core expertise in creating highly diverse compound libraries using novel multi-component chemistries.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2000 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal